EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieOpen Access · CC BY 4.0

Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo

Mohamed S Zaky, Rabie B Atallah, Nada Taha Ali El Abasy, Mohamed L Elsaie

Archives of Dermatological Research · 2024

DOI: 10.1007/s00403-024-03054-5 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Archives of Dermatological Research, 2024. Verfasst von Mohamed S Zaky und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Andrology, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt. Hauptthemen laut MEDLINE: Vitiligo, Tacrolimus, Bimatoprost. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Centre Egypt.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Loss and absence of melanocytes due to a number of factors is responsible for vitiligo; known to be the commonest disorder of pigmentation. The aim of the current work was to compare the efficacy and safety of excimer light with topical tacrolimus ointment 0.1% versus excimer light with topical bimatoprost gel 0.01% in treatment of facial vitiligo. The study was carried out on 48 patients presented with facial vitiligo. The patients were divided randomly using sealed envelope method into two groups (24 patients each). Group 1 were treated with excimer light plus topical tacrolimus ointment 0.1% and group 2 treated with excimer light plus topical bimatoprost gel 0.01%. Clinical improvement based on the quartile grading scale at the end of treatment did not show any statistically significant difference between groups. The majority of subjects in both groups experienced good to excellent improvement. Only 20.9% of patients in group 1 and 33.3% of subjects in group 2 achieved less than 50% repigmentation ( p = 0.889). Our study demonstrated that 0.01% topical bimatoprost gel in combination with excimer light is considered safe and effective as treatment of nonsegmental facial vitiligo with comparable results to 0.1% tacrolimus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

VitiligoTacrolimusBimatoprostHumansFemaleMaleAdultTreatment OutcomeYoung AdultAdolescentMiddle AgedLasers, ExcimerAdministration, TopicalSkin PigmentationFaceAdministration, CutaneousChildCombined Modality TherapyImmunosuppressive Agents

Stichwörter der Autor:innen

BimatoprostExcimerTacrolimusVitiligo

Substanzen

TacrolimusBimatoprostImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Andrology, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
  • Department of Dermatology, Damietta Dermatology and Leprosy Hospital, Damietta, Egypt.
  • Department of Dermatology, Medical Research and Clinical Studies Institute, National Research Centre, Giza, Egypt. Egydoc77@yahoo.com.

Förderung

  • National Research Centre Egypt

Zitieren

APA

Zaky, M. S., Atallah, R. B., El Abasy, N. T. A., & Elsaie, M. L. (2024). Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo. Archives of Dermatological Research. https://doi.org/10.1007/s00403-024-03054-5

Vancouver

Zaky MS, Atallah RB, El Abasy NTA, Elsaie ML. Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo. Archives of Dermatological Research. 2024. doi:10.1007/s00403-024-03054-5

BibTeX
@article{Zaky2024,
  author = {Zaky, Mohamed S and Atallah, Rabie B and El Abasy, Nada Taha Ali and Elsaie, Mohamed L},
  title = {Comparative study between efficacy of Excimer light with topical Tacrolimus 0.1% versus excimer light with topical Bimatoprost 0.01% in treatment of facial Vitiligo},
  journal = {Archives of Dermatological Research},
  year = {2024},
  doi = {10.1007/s00403-024-03054-5}
}
Kostenlos starten →